Eli Lilly and Co. LLY – Options Update
In our premarket report on Friday morning, we finished off with a set of fresh options ideas for the LLY chain, and were met with nice gain opportunities on the day on all accounts.
In addition to a daytrading idea with the LLY Weekly $72 and $72.50 Calls, which worked out in spades, we also got some really good initial movement out of the longer term target we put forth, the 01/20 $75 Calls.
Weekly $72 Calls – Range: .20-1.25 – Max Gain: 475%
Weekly $72.50 Calls – Range: .15-.80 – Max Gain: 433%
1/20 $75 Calls – Range: .77-1.39 – Max Gain: 81%
We offer congratulations to anyone who benefited from the short-term ideas, and we’ll be sure to stay on the trail of those 01/20 $75 Calls in the weeks ahead.
Globalstar, Inc. GSAT
We caught a glimpse of GSAT on our scanner this morning and feel it’s worthy of mentioning, based on a number of factors. Last week, the moves that the stock had been making off of its recent relative lows in the low .70-range began to increase.
On Thursday, the stock bullishly breached its 50DMA, culminating in a huge spike in volume on Friday. Roughly six times the monthly average trading volume accompanied a break of the dollar mark. We’re going to put this on watch as a possible momentum play.
AmpliPhi BioSciences, Inc. APHB
Speaking of bottom-bouncers, APHB cropped on our scan as well, and it has a look of high potential as it’s coming up off of its recently established annual lows.
In addition, there’s a gap to fill on the chart to the upside, and with the stock already trading up in the premarket, that’s a real possibility here. With such a ripe chart, we’ll be very interested to follow APHB’s activity out of the gate this morning.
Extended Watchlist:
NHMD, ECPN, EVOK, APTO, ANY(Bottom Play)